XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Oct. 31, 2020
Nov. 02, 2019
Operating activities:    
Net (loss) income $ (212,809,000) $ 186,494,000
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 123,094,000 136,355,000
Share-based compensation 24,685,000 19,946,000
Deferred income taxes 12,013,000 12,254,000
Loss on impairment of assets [1] 153,617,000  
Changes in assets and liabilities:    
Merchandise inventory (114,907,000) (223,181,000)
Operating lease assets 189,630,000 195,678,000
Operating lease liabilities (146,809,000) (203,077,000)
Other assets (86,501,000) (23,578,000)
Accounts payable 17,769,000 125,910,000
Accrued compensation and payroll taxes 74,374,000 (38,646,000)
Accrued and other liabilities (44,550,000) (9,955,000)
Net cash (used for) provided by operating activities (10,394,000) 178,200,000
Investing activities:    
Capital expenditures for property and equipment (92,591,000) (149,866,000)
Purchase of available-for-sale investments (14,956,000) (70,000,000)
Sale of available-for-sale investments 69,956,000 112,135,000
Other investing activities (511,000) (1,361,000)
Net cash used for investing activities (38,102,000) (109,092,000)
Financing activities:    
Repurchase of common stock as part of publicly announced programs (20,000,000) (112,381,000)
Repurchase of common stock from employees (5,357,000) (7,980,000)
Proceeds from revolving line of credit and convertible notes 736,108,000  
Principal payments on revolving line of credit (330,000,000)  
Net proceeds from stock options exercised 0 2,119,000
Cash dividends paid   (69,822,000)
Other financing activities (889,000) (83,000)
Net cash provided by (used for) financing activities 379,862,000 (188,147,000)
Effect of exchange rates changes on cash (940,000) 223,000
Net change in cash and cash equivalents 330,426,000 (118,816,000)
Cash and cash equivalents - beginning of period 361,930,000 333,330,000
Cash and cash equivalents - end of period $ 692,356,000 $ 214,514,000
[1] There were no impairment charges recorded during the 13 weeks ended October 31, 2020.  During the 39 weeks ended October 31, 2020, the Company recorded impairment charges of $153.6 million.  Of the total, $84.1 million related to the impairment of the operating lease ROU assets of 272 stores.  We recorded $51.5 million related to the impairment of certain corporate and store property and equipment.  We also recorded $18.0 million of impairment of certain cost and equity method investments.